3Saks VA , Dzhaliashvili IV, Konorev EA,et al. Molecular and cellular aspects of the cardioprotective mechanism of phosphocreatine[J].Biokhimiia, 1992,57(12): 1763-1784.
二级参考文献5
1Iberer F,Wasler A,Tscheliseeingg K,et al.Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance.Survival on waiting list and results of orthotopic heart transplanatation[].The Journal of Heart and Lung Transplantation.1993
2Deleuze PH,Benvenuti C,Mazzucotelli JP,et al.Orthotopic cardiac transplantation with direct caval anastomosis: is it the optimal procesure[].Journal of Thoracic and Cardiovascular Surgery.1995
3Srimivas M,Robert LK,Barry FU,et al.Preoerative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the pittsburgh eqperiemce[].American Heart Journal.1993
4Dreyfus G,Jebra VA,Mihailueanue S,et al.Toyal orthotopic heart transplantation, an alternative to the standard technipue[].The Annals of Thoracic Surgery.1991
5Michael MG,Joshua MH,Evanl,et al.Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction : Arapid test for reversibility of pulmonary hypertention[].Journal of the American College of Cardiology.1996
3Barnard CN. The operation.A human cardiac transplant:an interim report of a successful operation performed at Groote Schuur Hospital,Cape Town[J].{H}SOUTH AFRICAN MEDICAL Journal,1967,(48):1271-1274.
4Mascia L,Mastromauro I,Viberti S. Management to optimize organ procurement in brain dead donors[J].{H}Minerva Anestesiologica,2009,(03):125-133.
